Informatie:
Fout:
ID
21236
Beschrijving
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00313248
Link
https://clinicaltrials.gov/show/NCT00313248
Trefwoorden
Versies (1)
- 16-04-17 16-04-17 -
Geüploaded op
16 april 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Neoplasm NCT00313248
Eligibility Breast Neoplasm NCT00313248
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasm NCT00313248
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
metastatic breast cancer
Item
metastatic breast cancer (meaning the cancer has spread beyond its original location)
boolean
C0278488 (UMLS CUI [1])
breast cancer measurable lesion
Item
at least one measurable lesion by ct or mri
boolean
C0006142 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
C0011923 (UMLS CUI [1,3])
C1513041 (UMLS CUI [1,2])
C0011923 (UMLS CUI [1,3])
progression after breast cancer therapy
Item
progression of disease following previous therapy for breast cancer
boolean
C0006142 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,3])
anthracyclines or taxanes therapy
Item
have received previous treatment with anthracyclines (e.g. doxorubicin[adriamycin or doxil] or epirubicin [ellence]), taxanes (paclitaxel [taxol or abraxane] or docetaxel [taxotere]) for your breast cancer
boolean
C0282564 (UMLS CUI [1])
C0796419 (UMLS CUI [2])
C0796419 (UMLS CUI [2])
pregnancy
Item
not be pregnant
boolean
C0032961 (UMLS CUI [1])
additional inclusion criteria
Item
additional criteria to be determined at screening visit.
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])
previous chemotherapy regimens
Item
more than 3 previous chemotherapy regimens
boolean
C0392920 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,2])
breast cancer therapy with non cytotoxic agents
Item
more than one treatment with non cytotoxic agents for breast cancer therapy (e.g. herceptin [trastuzumab] or avastin [bevacizumab)
boolean
C0006142 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2827065 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C2827065 (UMLS CUI [1,3])
treatment with epothilones
Item
prior treatment with epothilones (e.g. ixabepilone)
boolean
C1136012 (UMLS CUI [1])
symptomatic brain metastases
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
additional exclusion criteria
Item
additional criteria to be determined at screening visit
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])